Skip to main content
. 2017 Oct 31;12(10):e0186821. doi: 10.1371/journal.pone.0186821

Fig 5. MTT viability assay on EEDQ LPs after different exposure time.

Fig 5

Viability of Hela cells (A), Hep G2 cells (B) and HEK-293T cells (C) after treatment with EEDQ2, LP-EEDQ2 or Tf-LP-EEDQ2 for different length of time. Cells treated with PBS were used as control. (*p<0.05, **p<0.01: LP-EEDQ2 VS Tf-LP-EEDQ2).